Salivary Metabolomics as a Diagnostic Tool: Distinct Metabolic Profiles Across Orofacial Pain Subtypes

被引:0
|
作者
Jasinska, Weronika [1 ,2 ]
Birenzweig, Yonatan [3 ]
Sharav, Yair [3 ]
Aframian, Doron J. [3 ]
Rettman, Andra [3 ]
Hanut, Aiham [3 ]
Brotman, Yariv [4 ]
Haviv, Yaron [3 ]
机构
[1] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel
[2] Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland
[3] Hebrew Univ Jerusalem, Fac Dent Med, Hadassah Med Ctr, Dept Oral Med Sedat & Imaging, POB 12272, IL-91120 Jerusalem, Israel
[4] Tel Aviv Univ, Sch Plant Sci & Food Secur, IL-6997801 Tel Aviv, Israel
关键词
craniofacial pain; oral fluids metabolomics; chronic pain; biomarkers; metabolite profiling; burning mouth syndrome; PHARMACOTHERAPEUTIC RESPONSE; ASSOCIATION;
D O I
10.3390/ijms26052260
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Orofacial pain (OFP) includes chronic pain conditions categorized into musculoskeletal (MS), neurovascular (NV), and neuropathic (NP) pain types, encompassing temporomandibular disorders (TMD), migraines, trigeminal neuralgia (TN), post-traumatic neuropathies, and burning mouth syndrome (BMS). These conditions significantly affect quality of life; yet, their underlying metabolic disruptions remain inadequately explored. Salivary metabolomics provides a non-invasive method to investigate biochemical alterations associated with OFP subtypes. This study aimed to identify pain-specific salivary metabolites across chronic OFP types and examine their correlations with clinical characteristics. Saliva samples from 63 OFP patients (TMD, migraines, TN, post-traumatic neuropathies, BMS) and 37 pain-free controls were analyzed using liquid chromatography-mass spectrometry (LC-MS) targeting 28 metabolites linked to pain. Statistical analyses determined significant metabolite changes and associations with pain subtypes and patient characteristics. Among the 28 analyzed metabolites, 18 showed significant differences between OFP patients and controls. Key amino acids, including DL-glutamic acid, DL-aspartic acid, DL-citrulline, spermidine, and DL-ornithine, were significantly elevated in MS, NV, and NP pain types compared to controls. Additionally, DL-glutamine, DL-valine, and DL-phenylalanine were distinctively elevated in TMD and migraine patients. BMS displayed fewer alterations, with significantly lower levels of DL-proline, DL-tryptophan, DL-glutamic acid, DL-asparagine, and DL-aspartic acid compared to other pain types but elevated spermidine levels relative to controls. Salivary metabolomics revealed distinct metabolic alterations in OFP subtypes, providing insights into potential biomarkers for diagnosis and monitoring. These findings offer a foundation for personalized approaches in OFP management, although further research is required to validate and expand these results.
引用
收藏
页数:12
相关论文
共 31 条
  • [1] Distinct DNA methylation profiles in subtypes of orofacial cleft
    Sharp, Gemma C.
    Ho, Karen
    Davies, Amy
    Stergiakouli, Evie
    Humphries, Kerry
    McArdle, Wendy
    Sandy, Jonathan
    Smith, George Davey
    Lewis, Sarah J.
    Relton, Caroline L.
    CLINICAL EPIGENETICS, 2017, 9
  • [2] Distinct DNA methylation profiles in subtypes of orofacial cleft
    Gemma C. Sharp
    Karen Ho
    Amy Davies
    Evie Stergiakouli
    Kerry Humphries
    Wendy McArdle
    Jonathan Sandy
    George Davey Smith
    Sarah J. Lewis
    Caroline L. Relton
    Clinical Epigenetics, 2017, 9
  • [3] Atypical orofacial pain disorders: a study of diagnostic subtypes.
    Fricton J.R.
    Current Review of Pain, 2000, 4 (2): : 142 - 147
  • [4] Salivary Endocannabinoid Profiles in Chronic Orofacial Pain and Headache Disorders: An Observational Study Using a Novel Tool for Diagnosis and Management
    Heiliczer, Shimrit
    Wilensky, Asaf
    Gaver, Tal
    Georgiev, Olga
    Hamad, Sharleen
    Nemirovski, Alina
    Hadar, Rivka
    Sharav, Yair
    Aframian, Doron J.
    Tam, Joseph
    Haviv, Yaron
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [5] Untargeted metabolomics combined with chemometrics reveals distinct metabolic profiles across two sparkling cider fermentation stages
    Li, Wenting
    Guo, Qi
    Zhao, Yuning
    Yue, Tianli
    Yuan, Yahong
    FOOD RESEARCH INTERNATIONAL, 2024, 195
  • [6] Identification of Distinct Metabolic Profiles in Childhood Hypercholesterolemia Using Metabolomics Analysis
    Gu, Pei-Shin
    Su, Kuan-Wen
    Chiu, Chih-Yung
    Lo, Fu-Sung
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 244 - 244
  • [7] Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature
    Sarode, Gaurav V.
    Kim, Kyoungmi
    Kieffer, Dorothy A.
    Shibata, Noreene M.
    Litwin, Tomas
    Czlonkowska, Anna
    Medici, Valentina
    METABOLOMICS, 2019, 15 (03)
  • [8] Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature
    Gaurav V. Sarode
    Kyoungmi Kim
    Dorothy A. Kieffer
    Noreene M. Shibata
    Tomas Litwin
    Anna Czlonkowska
    Valentina Medici
    Metabolomics, 2019, 15
  • [9] Correction to: Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature
    Gaurav V. Sarode
    Kyoungmi Kim
    Dorothy A. Kieffer
    Noreene M. Shibata
    Tomas Litwin
    Anna Czlonkowska
    Valentina Medici
    Metabolomics, 2020, 16
  • [10] Serum metabolomics study reveals a distinct metabolic diagnostic model for renal calculi
    Xiong, Yunhe
    Song, Qianlin
    Zhao, Shurui
    Wang, Chuan
    Ke, Hu
    Liao, Wenbiao
    Meng, Lingchao
    Liu, Lingyan
    Song, Chao
    HELIYON, 2024, 10 (11)